Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Intimation under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations")'.
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gaudium IVF and Women Health Limited has informed the stock exchanges that its Board of Directors has authorized three Key Managerial Personnel to determine the materiality of events or information and make disclosures to the exchanges under Regulation 30 of the SEBI Listing Regulations. The authorized persons are Dr. Manika Khanna (Chairperson & Managing Director), Mr. Rakesh Kumar Sharma (Chief Financial Officer), and Mr. Naveen Kumar (Company Secretary & Compliance Officer). This is a routine compliance filing required under Regulation 30(5), and the disclosure is also available on the company's website.
This is a standard governance and compliance disclosure with no direct impact on business operations or stock price. It simply formalizes the internal process for identifying and reporting material events to the exchanges going forward.